-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Tclu98SHXK/DbRn4TYSqvz1Z2jOTJNjfRLlsYRj/HNc14+fTAxQQ5+BAI5CsOTYc +RcEie9PHMg5rtXb1d1XHQ== /in/edgar/work/0000950124-00-005835/0000950124-00-005835.txt : 20000930 0000950124-00-005835.hdr.sgml : 20000930 ACCESSION NUMBER: 0000950124-00-005835 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20000928 GROUP MEMBERS: DANIEL ASHER GROUP MEMBERS: OAKMONT INVESTMENTS, LLC GROUP MEMBERS: PYRAMID TRADING LTD PARTNERSHIP /IL SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDTOX SCIENTIFIC INC CENTRAL INDEX KEY: 0000739944 STANDARD INDUSTRIAL CLASSIFICATION: [2835 ] IRS NUMBER: 953863205 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-37329 FILM NUMBER: 731330 BUSINESS ADDRESS: STREET 1: 402 WEST COUNTY ROAD D CITY: ST PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 6126367466 MAIL ADDRESS: STREET 1: 402 WEST COUNTY ROAD D CITY: ST PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: EDITEK INC DATE OF NAME CHANGE: 19940902 FORMER COMPANY: FORMER CONFORMED NAME: ENVIRONMENTAL DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PYRAMID TRADING LTD PARTNERSHIP /IL CENTRAL INDEX KEY: 0001107219 STANDARD INDUSTRIAL CLASSIFICATION: [ ] IRS NUMBER: 363723624 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 440 SO LASALLE ST SUITE 700 CITY: CHICAGO STATE: IL ZIP: 60605 BUSINESS PHONE: 3123624000 MAIL ADDRESS: STREET 1: 440 SO LASALLE ST SUITE 700 CITY: CHICAGO STATE: IL ZIP: 60605 SC 13D 1 c57704sc13d.txt SCHEDULE 13D 1 SCHEDULE 13D (RULE 13d-101) Information to be Included in Statements Filed Pursuant to Rule 13d-1(a) and Amendments Thereto Filed Pursuant to Rule 13d-2(a) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Medtox Scientific, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock and Warrants - -------------------------------------------------------------------------------- (Title of Class of Securities) 586999-40-1 - -------------------------------------------------------------------------------- (CUSIP Number) Robert T. Montague Robins, Kaplan, Miller & Ciresi 800 LaSalle Avenue, Suite 2800 Minneapolis, MN 55408 612-349-8500 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 31, 2000 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box / /. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 CUSIP NO. 586999-40-1 13D PAGE 2 OF 9 PAGES - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Pyramid Trading Limited Partnership 36-3723624 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) WC - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Illinois - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 0 Shares SHARES ----------------------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 280,000 Shares OWNED BY EACH ----------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER REPORTING 0 Shares PERSON ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER WITH 280,000 Shares - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 280,000 Shares - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.2% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) BD, PN, IV - -------------------------------------------------------------------------------- 3 CUSIP NO. 586999-40-1 13D PAGE 3 OF 9 PAGES - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Oakmont Investments, LLC 36-3996171 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) N/A - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Illinois - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 0 Shares SHARES ----------------------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY 280,000 Shares OWNED BY EACH ----------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER REPORTING 0 Shares PERSON ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER WITH 280,000 Shares - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 280,000 Shares - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.2% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) CO, IV - -------------------------------------------------------------------------------- 4 CUSIP NO. 5869999-40-1 13D PAGE 4 OF 9 PAGES - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Daniel Asher, ###-##-#### - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) N/A - -------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 Shares NUMBER OF SHARES ----------------------------------------------------------------- 8 SHARED VOTING POWER 280,000 shares BENEFICIALLY OWNED BY EACH ----------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER 0 shares REPORTING PERSON ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 280,000 shares WITH - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 280,000 shares - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.2% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) - -------------------------------------------------------------------------------- 5 5 of 9 CUSIP No.586999-40-1 ITEM 1. SECURITY AND ISSUER The class of equity securities to which this Statement on Schedule 13D relates is the common stock, par value $.15 per share ( the "Common Stock") and a warrant (the "Warrant") to purchase shares of Common Stock, of Medtox Scientific, Inc., a Delaware corporation (the "Company"). The principal executive offices of the Company are located at 402 West County Road D, St. Paul, MN 55112. ITEM 2. IDENTITY AND BACKGROUND This statement is being filed by Pyramid Trading Limited Partnership ("PT"), Oakmont Investments, LLC, the general partner of PT ("OI") and Daniel Asher, as Manager of OI and individually ("DA"). PT, OI and DA are collectively referred to herein as the "Reporting Persons." The following information relates to PT: (i) Name: Pyramid Trading Limited Partnership (ii) State of Organization: Illinois (iii) Principal Business: Broker-Dealer registered on CBOE (iv) Principal Business and Office Address: 440 S. LaSalle Street, Chicago, Illinois 60605 (v) Information required by clauses (d) an (e) of Item 2 or Schedule 13D: None. The following information relates to OI: (i) Name: Oakmont Investments LLC (ii) State of Organization: Illinois (iii) Principal Business: Investments (iv) Principal Business and Office Address: 440 S. LaSalle Street, Chicago, Illinois 60605 (v) Information required by clauses (d) an (e) of Item 2 or Schedule 13D: None. The following information relates to DA: (a) Name: Daniel Asher (b) Business Address: 440 S. LaSalle Street, Suite 700, Chicago, Illinois 60605 (c) Principal Occupation: Private Investor Manager of Oakmont Investments, LLC 6 6 of 9 CUSIP No.586999-40-1 (d) Criminal Proceedings: None (e) Civil Proceedings: None (f) Citizenship: United States ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION On 07/31/00 PT purchased from the Company in a private placement 40,000 unregistered shares of Common Stock and a Warrant (exercisable for five years from 07/31/00) to purchase an additional 40,000 shares. On 08/31/00 PT purchased an additional 100,000 unregistered shares of Common Stock and a Warrant (exercisable for five years from 08/31/00) to purchase an additional 100,000 shares. PT acquired the Common Stock and Warrants using working capital. ITEM 4. PURPOSE OF TRANSACTION For investment. The Reporting Persons have no present plans or proposals that relate to or would result in any of the matters set forth in clauses (a) through (j) which would result in or relate to Item 4 of Schedule 13D. The Company is obligated to file a registration statement with the Securities and Exchange Commission in order to register the shares of Common Stock purchased and the shares underlying the Warrant. The Reporting Persons are not obligated to hold the shares following such registration and they may add to their position or sell shares in open market transactions or otherwise. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER (a) As of 08/31/00 the Reporting Persons beneficially owned the amounts of Common Stock and Warrant to purchase Common Stock respectively set forth below. The percentage set forth below represents the percentage of the outstanding shares of Common Stock based on 3,404,346 shares outstanding as of 08/04/00 as set forth in the Company's Form 10Q for the quarter ended 06/30/00.
Reporting Shares of Percent of Person Common Stock Outstanding Common Stock - --------- ------------ ------------------------ PT, OI, DA 280,000(1) 8.2
- ---------------- 1 Includes 140,000 shares of Common Stock and Warrants to purchase an additional 140,000 shares exercisable within (sixty) 60 days. (b) The information set forth in Items 7 through 11 of the cover pages hereto is incorporated herein by reference. 7 7 of 9 CUSIP No.586999-40-1 (c) The shares and warrants reported herein are the only transactions in the Common Stock effected by the Reporting Persons during the past sixty (60) days. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIP WITH RESPECT TO THE SECURITIES OF THE ISSUER None. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS 1. Agreement dated as of September 27, 2000 by and among the signatories of this Statement on Schedule 13D with respect to its filing. SIGNATURE After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: September 26, 2000 PYRAMID TRADING LIMITED PARTNERSHIP BY: OAKMONT INVESTMENTS, LLC ITS: GENERAL PARTNER BY: /S/ Daniel Asher ------------------------------- Daniel Asher Manager, Oakmont Investments, LLC OAKMONT INVESTMENTS, LLC BY: /S/ Daniel Asher ------------------------------- Daniel Asher, Manager /s/ Daniel Asher ----------------------------------- DANIEL ASHER 8 8 of 9 CUSIP No.586999-40-1 EXHIBIT INDEX EXHIBIT NO. DOCUMENT 1 Agreement, dated as of September 26, 2000 by and among the signatories of this Statement with respect to its filing. TYPE: EX-1 SEQUENCE: 2 DESCRIPTION: AGREEMENT DATED AS OF SEPTEMBER 26, 2000 EX-1 2 c57704ex1.txt AGREEMENT DATED AS OF SEPTEMBER 2, 2000 1 CUSIP No.586999-40-1 EXHIBIT 1 AGREEMENT This will confirm the agreement by and among all the undersigned that the Schedule 13D filed on or about this date with respect to the beneficial ownership of the undersigned of shares of Common Stock of Medtox Scientific, Inc. is being filed on behalf of each of the signatories names below. This agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Date: September 26, 2000 PYRAMID TRADING LIMITED PARTNERSHIP BY: OAKMONT INVESTMENTS, LLC ITS: GENERAL PARTNER BY: /S/ Daniel Asher --------------------------------------- Daniel Asher Manager, Oakmont Investments, LLC OAKMONT INVESTMENTS, LLC BY: /S/ Daniel Asher --------------------------------------- Daniel Asher, Manager /s/ Daniel Asher ------------------------------------------- DANIEL ASHER -----END PRIVACY-ENHANCED MESSAGE-----